|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,230.00 KRW | -0.19% |
|
+13.70% | -23.31% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.19% | +13.70% | +15.58% | -29.61% | -23.31% | -35.19% | - | - | - | 87.76M | |
| -2.76% | +15.94% | +16.12% | +57.41% | +36.83% | +99.61% | +487.67% | +196.65% | +2,908.30% | 46.43B | |
| -0.21% | +4.02% | +15.52% | +25.36% | +27.46% | +19.47% | +49.42% | +6.01% | +128.17% | 25.88B | |
| +0.67% | +2.56% | +5.46% | +18.21% | -0.93% | -18.72% | -34.64% | -45.45% | +2.10% | 7.76B | |
| +7.97% | +15.31% | +17.42% | +37.80% | +7.96% | +24.24% | +141.40% | +128.78% | +1,136.44% | 5.69B | |
| +1.16% | +2.82% | +15.43% | +18.25% | +31.80% | +21.40% | +65.56% | +0.56% | +332.01% | 3.39B | |
| +0.54% | +14.46% | +18.33% | +96.09% | -40.28% | -29.74% | +1,359.96% | -80.77% | - | 2.3B | |
| +0.33% | +5.15% | +18.04% | +92.32% | +41.62% | +186.17% | +18.08% | -60.64% | +106.89% | 2.13B | |
| +3.35% | +4.36% | +26.56% | +2.99% | +2.15% | -4.07% | -56.01% | -78.70% | - | 1.99B | |
| +3.62% | +11.34% | +10.80% | -3.65% | +28.20% | +28.61% | -12.34% | -41.81% | -35.33% | 1.84B | |
| +3.07% | +2.85% | +0.25% | +3.72% | +31.25% | +32.63% | +190.12% | - | - | 1.46B | |
| +1.76% | +5.24% | +4.58% | +13.62% | +4.55% | +2.20% | +36.05% | +19.38% | -29.70% | 1.21B | |
| -0.36% | +4.96% | +1.85% | +22.77% | +9.13% | +5.77% | -24.45% | -62.84% | -86.14% | 1.02B | |
| +2.99% | +5.20% | +20.52% | +29.45% | +39.37% | +40.27% | +225.39% | +40.37% | +237.37% | 1.01B | |
| +12.24% | +16.82% | +16.92% | -1.72% | +11.90% | -7.59% | -36.28% | -76.26% | - | 892M | |
| -0.42% | +1.13% | -2.19% | -5.30% | -7.38% | +0.28% | +23.28% | -13.12% | +38.30% | 853M | |
| -2.29% | -0.47% | +3.40% | -4.05% | -16.14% | -21.40% | -30.62% | -59.66% | +28.31% | 574M | |
| +5.94% | +7.87% | +12.49% | -13.29% | +2.27% | -11.67% | -40.95% | - | - | 559M | |
| +14.65% | +21.46% | +0.25% | -11.24% | -9.30% | +22.79% | +16.59% | - | - | 553M | |
| -1.15% | +7.50% | -7.88% | +19.66% | -27.94% | -8.15% | -41.79% | -80.55% | - | 527M | |
| Average | +2.54% | +8.50% | +10.47% | +18.44% | +7.46% | +17.35% | +122.97% | -13.00% | +397.23% | 5.31B | |
| Weighted average by Cap. | -0.33% | +11.98% | +14.56% | +39.73% | +25.37% | +53.15% | +265.54% | +86.60% | +1,495.75% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
